Princeton, NJ, United States of America

Gerrit Dispersyn




Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Pennington, NJ (US) (2013)
  • Princeton, NJ (US) (2015)

Company Filing History:


Years Active: 2013-2015

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Gerrit Dispersyn: Innovator in Pharmaceutical Compositions

Introduction

Gerrit Dispersyn is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of itraconazole compositions that enhance bioavailability. With a total of 2 patents to his name, Dispersyn's work is recognized for its innovative approach to drug formulation.

Latest Patents

Dispersyn's latest patents focus on itraconazole compositions with improved bioavailability. One of his notable inventions is a solid dispersion product comprising itraconazole and hydroxypropyl methylcellulose. This product satisfies the formula 0.35 > ΔH(1), where ΔH represents the endotherm (J/g) accompanying a transition at about 240°C. The solid dispersion product demonstrates an improved bioavailability, making it a significant advancement in pharmaceutical formulations.

Career Highlights

Throughout his career, Gerrit Dispersyn has worked with prominent companies in the pharmaceutical industry. He has been associated with Abbott GmbH & Co. KG and AbbVie Deutschland GmbH & Co. KG. His experience in these organizations has contributed to his expertise in drug development and formulation.

Collaborations

Dispersyn has collaborated with several professionals in his field, including Gunther Berndl and Matthias Degenhardt. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in pharmaceutical compositions.

Conclusion

Gerrit Dispersyn is a distinguished inventor whose work in itraconazole compositions has made a significant impact on the pharmaceutical industry. His innovative approaches and collaborations highlight his commitment to improving drug formulations and enhancing patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…